FROM time to time new agents used in anaesthesia are synthesized with a view to improving upon or superseding established drugs. This is a welcome trend, since once in a while an agent is found which is, in many respects, superior to previously known drugs and which fills a definite clinical need. Most of the new agents, however, must be discarded, not so much because of their lack of clinical suitability but because the clinician finds no real need for the new drug. Frequently the promising impressions gained from animal experiments are not fufilled when the agent is subsequently tested in man. When it does come up to expectations, the clinician must still determine whether the new drug has sufficient advantages over established agents to warrant its introduction into clinical anaesthesia, however good the new drug may be. If critical comparisons are not carried out, the market becomes saturated with innumerable similar compounds all claiming this or that advantage over the other, but none serving a really useful purpose. Clinical impressions of new agents are notoriously misleading. After the pharmacological properties of the agent have been established in animals, it becomes the duty of the clinician first to determine, as far as possible, the pharmacological properties of the new drug in man and, if possible, to compare them quantitatively and qualitatively with those of established agents which serve as standards for comparison. If such comparative studies under controlled conditions suggest to the investigators that there is some merit in a«new drug, then and only then, should it be used under actual clinical conditions in order to assess its usefulness when administered * From the Department of Anaesthesia, University of Saskatchewan College of Medicine and University Hospital. Saskatoon, Canada. after pre-operative medication, with other anaesthetic agents, and in the presence of the many complicating factors due to disease and operation.
In the past, anaesthetists, as a group, have been much too indulgent in accepting new agents which, although they have enjoyed a brief period of popularity, have soon fallen into disuse or have found very limited application in only a few centres. If these drugs had never reached the open market, anaesthesia would have been none the poorer.
With these thoughts in mind we have compared under controlled conditions the comparative properties of seven intravenous anaesthetic agents in man. Three of these agents are clinically established barbiturates; three others are new or experimental barbiturates; and one is a new nonbarbiturate drug. We have attempted to determine whether any of the four new agents have sufficient merit to recommend their adoption for clinical use, and we have also attempted to re-evaluate some of the properties in man of the three established drugs.
The seven drugs studied, their generic names, chemical names and structural formulae are listed in table I. With the exception of Dolitrone, they are all barbiturates. All agents are sodium salts of an acid and are dispensed in powder form. They are dissolved in distilled water or normal saline prior to use because the solutions tend to deteriorate after varying periods of time. Dolitrone deteriorates quite rapidly in solution and must be prepared immediately prior to use. Pentothal (thiopentone), Surital (thiamylal) * All are manufacturers' data with the exception of Neraval (Boone et al., 1956; Fitzpatrick et al., 1956) . pH varies within the ranges indicated according to concentration and solvent. t 2.5 per cent solutions in distilled water at 25°C.
For the sake of simplicity we shall throughout this paper refer to these agents by their official approved names as listed in 
METHOD OF STUDY
Experiments were carried out on five subjects, all of whom were young, healthy males. All were submitted to seven tests each, one for each drug studied. The average interval between each test was one week.
On the morning before the first experiment, plasma volume was determined by the use of radio-active iodinated human serum albumin (albumin I 131; RIHSA Abbott), and a haemotocrit determination was carried out. From these the total blood volume was estimated.
Having had no nourishment for at least six hours, the subjects were admitted to the recovery room at least one hour before the experiment. At this time their height and weight were recorded. No premedication whatsoever was administered.
At the start of each experiment, a No. 18 Riley needle was inserted into the brachial artery, a No. 18 needle was inserted into the median basilic vein, and another intravenous needle with a Gordh needle mount was inserted into a vein on the opposite arm. The arterial and venous needles were connected to Statham strain gauges and arterial and venous blood pressures were directly observed on the screen of a six channel recorder, together with the electrocardiogram. Continuous permanent photographic tracings were made of these recordings.
The subject then breathed into a recording spirometer filled with oxygen and provided with a carbon dioxide absorption canister filled with fresh baralyme. After respiration appeared to be stabilized, RIHSA 50 to 75 microcuries was injected intravenously and radioactivity noted by means of a scintillation counter placed over the outflow tract at the left second interspace immediately adjacent to the sternum. From the resultant curve, cardiac output was calculated.
After recording all baseline values, the intravenous agent to be examined was injected. The sequence of drugs used was arranged by previously prepared random assignment for each volunteer in order to control the possibility of tolerance effects despite the interval of one week between tests. If such a tolerance effect did exist it would not manifest itself to the same degree in the same drug but the effect would be spread over all agents. All intravenous agents were freshly prepared 2.5 per cent solutions and were injected at the rate of 1 ml (25 mg) in approximately 1.5 seconds until the individual closed his eyes. After a short pause the sleep dose thus determined was repeated with moderate rapidity. Immediately upon completion of the injection, another cardiac output study was done by means of albumin-bound I 131. Respiration, arterial and venous blood pressures and electrocardiogram were continuously recorded from the moment of injection until the completion of the experiment. This point was considered to have been reached when the subject opened his eyes upon verbal command.
Great care was taken during the experiment to maintain absolutely unobstructed respiration 196 BRITISH JOURNAL OF ANAESTHESIA which, in most instances, was achieved without the use of an oral or nasal airway. One of these, however, was inserted if maintenance of a clear airway proved difficult. No endotracheal tubes were used. Apnoea following induction was permitted to persist for one minute. After one minute the subject's lungs were ventilated by compression of the chest until spontaneous respiration resumed.
Upon completion of the experiment, the individuals were returned to the recovery room, where they were permitted to rest until full recovery had taken place. Meanwhile, their rate of recovery, the presence of headache, diplopia, return of normal gait and their individual impressions of the agent were all recorded.
RESULTS
The vital statistics of the five subjects, including age, height, weight, body surface area, plasma volume and total blood volume are listed in table III. All five were roughly of the same age. The body surface area of three subjects was average for individuals in that age group; it was above average for the other two.
Dose. I. General Findings.
The double sleep doses required for each subject and for each drug are listed in table IV. Since there appears to be a marked individual variation for the same agent, the dose as related to body surface area was calculated ( subject 2 exhibited after both drugs very slight spontaneous movements of the foot as anaesthesia became lighter towards the second half of the experiment.
Hexobarbitone. Although moderately satisfactory on the whole, was accompanied by spontaneous, often jerky, movements of the extremities in all instances. Subjects 4 and 5 exhibited a short period of generalized spasticity after completion of the injection which, after a short period, was followed by general relaxation. Crowing occurred in subject 1 and periodic respiration in subject 2.
Buthalitone. Anaesthesia was smooth in two instances (subjects 2 and 3). In subject 1 anaesthesia was complicated by violent coughing, spontaneous movements, excessive salivation and swallowing early during the anaesthesia, as well as partial obstruction due to cord spasm. All these resolved after a while and anaesthesia then was smooth. Cough, spontaneous movements and jerking of the legs were also observed in subject 5, while subject 4 exhibited hiccough and crowing, followed by marked spontaneous movements.
Methitural. Only four administrations were analyzed because subject 1 moved spontaneously during injection of the single sleep dose, dislodging the intra-arterial needle, so that the experiment had to be discontinued. Anaesthesia was smooth in one case (subject 4). Subject 2 had violent spasmodic cough at the end of the injection which necessitated the temporary administration of oxygen for one minute; this was followed by relatively smooth anaesthesia except for some cough as well as forced expiration and inspiration which made airway maintenance somewhat difficult. Subject 3 had violent coughing^ spontaneous movements and wheezing with stridor and cyanosis, irregular jerky respirations, and later there was marked struggling and salivation. Spontaneous movements of arms and legs and groaning were experienced with subject 5.
Compound 25398 was the most unsatisfactory from the point of view of smoothness of anaesthesia. There was not one single smooth breathing pattern, all showing jerky respiration with crowing 3 twitching, marked spontaneous movements and respiratory obstruction at the level of the vo?al cords (figs. 1 and 2). Respiration, as a rule, was laboured; there was hiccough in one instance and unexplained early cyanosis in another. All these manifestations were so marked that great anxiety was experienced by the investigators during each administration. Dolitrone. Anaesthesia was entirely smooth in one instance, but there was some twitching of the arms followed by sighing in two cases and mild spontaneous movements in two cases, and subject 5 exhibited laboured respiration throughout.
Wakening time. Table VII shows again the very marked individual variations for the same drug from subject to subject. With one exception, subject 1 seemed to reach the end point of the experiment always later than all others and, in the instance of thiopentone same quick awakening and absence of hangover were noticeable with buthalitone and methitural except that subject 3 was very wild and excited immediately on wakening from methitural. He then had a period of coughing, whereupon he fell into a secondary sleep and required some time to awaken therefrom. This was a case where marked stfidor, some cyanosis and cough were experienced during the anaesthesia, and it may well be that the postanaesthetic manifestations were due to the resultant hypoxia. Despite the tremenduous difficulties of maintaining anaesthesia with Compound 25398, wakening was smooth, and the subjects felt quite well afterwards. There was some evidence of euphoria but 
Postanaesthetic manifestations.
All subjects experienced prolonged drowsiness, unsteadiness and hangover after thiopentone and thiamylal and, in a majority of cases, diplopia was also experienced when the individuals tried to focus. The postanaesthetic period with hexobarbitone was very satisfactory, most subjects being entirely rational and lucid very soon after wakening. They made such comments as " I feel tremendous" or " Never felt so good". The no dizziness, nausea or emesis. Awakening after Dolitrone was likewise fast and smooth. //. Cardiovascular Responses Average systolic blood pressure, diastolic blood pressure, pulse pressure and pulse rate have been calculated for the average duration of anaesthesia for each agent. No electrocardiographic changes were observed in any of the experiments. Cardiac output and venous pressures will be the subject of a further report (Dobkin and Wyant, 1957) . Table VIII shows the average pre-anaesthetic blood pressures and pulse rates of all five subjects for each agent. Since the same individuals were involved in each experiment one would expect control values to be very similar. Only for hexobarbitone was the pre-anaesthetic average blood pressure elevated as compared with the other averages. Almost all subjects exhibited preanaesthetic tachycardia, which was most marked preceding the rhiopentone administration. These data must be borne in mind in interpreting average percentage variations after administration. Systolic blood pressure ( fig. 3) . All agents showed an immediate postinjection fall of systolic blood pressure lasting from 20 seconds (Dolitrone) to 2 minutes (methitural). Only in the case of hexobarbitone did this initial drop persist unchanged throughout the experiment. In no case was the drop less than 10 per cent. It was between 10 and 20 per cent for thiopentone, thiamylal, buthalitone, methitural and Dolitrone. The initial systolic blood pressure fall exceeded 20 per cent in the case of hexobarbitone and Compound 25398. With the exception of hexobarbitone, the systolic blood pressure after the initial fall rose, but this was almost insignificant for four of the agents, ranging between 2 and 4 per cent. Dolitrone showed the most significant rise from the initial depression since within 3 minutes from the end of injection the blood pressure reached a 4 per cent depression from an initial fall of 18 per cent, and after a further 3 minutes the depression of systolic pressure was only 2 per cent. The return of systolic blood pressure for Compound 25398, from 28 per cent of normal to 11.5 per cent of normal, took 2 minutes, but later two further drops occurred. The irregularity of the tracing for Compound 25398 must be interpreted in the light of movements, coughing and partial respiratory obstruction from cord spasm, all of which occurred with every administration.
If the findings for hexobarbitone are adjusted to a pre-anaesthetic average pressure similar to that preceding the other compounds (broken line), the percentage depression for hexobarbitone likewise falls between 10 and 20 per cent and is equal to that of thiopentone after the initial drop. Diastolic blood pressure ( fig. 4) . Diastolic blood pressure also fell in every instance and was in all cases between 10 and 20 per cent. With methitural a further very slight drop of diastolic pressure to below 20 per cent occurred 2 minutes later; with hexobarbitone no change resulted after the. initial drop for the remainder of the experiment. Within a short period of time, both Dontrone and Compound 25398 showed a very significant rise of diastolic pressure, which soon rose above preanaesthetic levels. In interpreting the findings for Compound 25398, the previously mentioned technical difficulties must be borne in mind. In the remaining three compounds (thiopentone, thiamylal and .buthalitone), a slight rise of diastolic blood pressure occurred after the initial drop, but only in the case of buthalitone did this bring the depression to less than 10 per cent of preanaesthetic values.
Pulse pressure (fig. 5 ). Immediate postanaesthetic drop in pulse pressure was least for methitural (less than 10 per cent), and after two minutes the pulse pressure returned to pre-anaesthetic values. The initial fall in pulse pressure for thiamylal reached 20 per cent; it was between 20 and 30 per cent for buthalitone and Dolitrone; it was 30 per cent for thiopentone; and it exceeded 30 per cent for hexobarbitone and Compound 25398. The depression of pulse pressure was maintained without any change for hexobarbitone, was significantly reduced for thiopentone, and was very significantly reduced within 5 minutes for Dolitrone. The subsequent rise for thiamylal amounted to only 5 per cent, but buthalitone showed a continuous diminution of pulse pressure for the first 5 minutes to 23 per cent of normal. The initial fall for Compound 25398 was very significant indeed, reaching 45 per cent; in the course of the next 5 minutes it rose in a stepladder-like fashion to 10 per cent of normal. The initial fall, being uncomplicated by technical difficulties, is probably valid, but all subsequent findings must be interpreted with caution.
Pulse pressure again was adjusted for average pre-anaesthetic values in the case of hexobarbitone, which is indicated by the broken line. After correction, the pulse pressure values for hexobarbitone are similar to those for thiopentone after the initial drop.
Pulse rate (fig. 6 ). The least change of pulse rate occurred with methitural, being practically insignificant. Buthalitone is the only other agent which showed an elevation not exceeding 10 per cent. Thiopentone and thiamylal showed an eleva- tion of pulse rate exceeding 10 per cent. This elevation was maintained with thiopentone; with thiamylal it returned after 5 minutes to a level very similar to that of thiopentone. The elevation of pulse rate for hexobarbitone exceeded 20 peT cent and was maintained at this level throughout. The initial tachycardia with Dolitrone reached 38 per cent but was maintained at this level for only 30 seconds and then gradually fell to an eventual increase of 18 per cent above normal. For Compound 25398, the initial rise was to almost 40 per cent for 90 seconds, whereupon a very gradual decrease to a final level of 23 per cent above normal occurred. As stated previously, the pre-anaesthetic average pulse rate for thiopentone was higher than for all other agents (table VuT) . Values have been corrected for an average pulse rate and are indicated by the broken line.
with an average apnoea of 87 seconds, showed by far the longest period of apnoea.
The most significant feature for thiopentone was the fact that four out of five subjects showed a short period of apnoea lasting a few seconds during injection, succeeded by a few breaths of a reasonably adequate tidal volume, and followed by the main apnoea after completion of the injection (figs. 7 and 8). After thiamylal it occurred only .once. Delayed single apnoea occurred once with hexobarbitone, once with buthalitone and twice after Compound 25398.
Tidal volumes. Figure 9 shows the average tidal volumes for the five subjects for the average duration of anaesthesia. With thiopentone, thiamylal and Dolitrone it was relatively easy to compound these averages because respiratory patterns were moderately regular and breath-to-breath variations stayed within reasonable limits. For (table IX) . Tidal volumes of less than 40 ml were considered to constitute a state of apnoea when they followed immediately upon a period of cessation of respiration. Again marked individual variations were noted for each agent. Averages seem to indicate that by far the shortest average period of apnoea occurred after the injection of double the sleep dose of methitural (2.5 seconds), with hexobarbitone (10 seconds) next in line. Buthalitone and Dolitrone are similar with 20 and 22.2 seconds respectively. The average period of apnoea with thiamylal was 29 seconds and only two of the five subjects became apnoeic at all. The average time of apnoea for thiopentone was 38 seconds, each subject becoming apnoeic following the injection. Compound 25398, * Unsatisfactory tracing. methitural some difficulty in averaging was encountered for the first and second minutes following apnoea, but thereafter respiratory patterns were reasonably smooth. With hexobarbitone, buthalitone and Compound 25398, we met with considerable difficulty in calculating averages because of the wider variations in tidal volume from breath to breath. The values obtained and charted must therefore be interpreted in that light. After Compound 25398 irregular tracings were due to airway difficulty because of laryngospasm, coughing, breath holding, etc., in contrast to the irregular breathing patterns after hexobarbitone which occurred in the presence of a free airway. Wavy lines are used in order to indicate this difficulty in calculating averages. Two tracings for buthalitone showed such irregular breathing patterns due to coughing that they could not be included in the calculation of averages. With the exception of hexobarbitone, where tidal volumes were rather large following induction of anaesthesia, all other agents averaged 300 ml (or slightly more) per breath initially. Only thiopentone showed a significant increase of tidal volume after 10 minutes from the end of the injection.
Respiratory rate. Averages for respiratory rate are charted in figure 10 . A respiratory rate of 18 to 22 per minute was obtained for all agents, with only Dolitrone and Compound 25398 showing initially a slight degTee of tachypnoea.
Minute volume. The minute volume was calcu-BRITISH JOURNAL OF ANAESTHESIA lated from tidal volume and rate. Averages are shown in figure 11 . Methitural gave the lowest minute volume (because of the slow respiratory rate), but the average of slightly above 5 litres per minute is an acceptable value. All other agents gave a minute volume of over 6 litres per minute. Thiopentone showed the most marked increase (to over 10 litres per minute) 16 minutes after the end of injection. The tidal volume following injection of hexobarbitone averaged 10 litres per minute with an initial ventilation of more than 11 litres per minute. This large minute volume is probably an expression of the marked irregularity of respiration throughout the period of observation. 
DISCUSSION
When considering the results obtained in a study of this kind, it must be borne in mind that, despite all precautions, two important factors cannot be controlled. The first of these variables is the degree of pre-anaesthetic apprehension which may exist to a greater or lesser degree. Some degree of control was hoped for by varying the sequence of administration of the various drugs for each subject, since it was assumed that apprehension would be greatest before the first experiment. However, when the average blood pressure and pulse rate of the subjects for each drug were calculated, there was an appreciable difference. Theoretically these averages should have been identical, inasmuch as they involved the total anaesthetic experience of the same individuals.
One of the reasons for this discrepancy may have been either occasional difficulty in placing the intra-arterial needle or other technical difficulties before the start of the experiment. The second variable which could not be controlled was the state of wakefulness or tiredness of the individuals at the time of any given experiment. On one or two occasions it was related afterwards that the subject had had a late night and felt rather tired before the beginning of the experiment, which had its invariable repercussions in the dose requirement and the duration of postanaesthetic sleep. These two variables could only have been controlled if a much larger number of subjects were studied than we were able to procure for this series. Unfortunately, this is impossible in projects of this type. One further difficulty in our study has been the determination of an end point. The end point was determined, quite arbitrarily, as the instant the patient first opened his eyes on verbal command. In two instances (once after buthalitone and once after methitural), the subjects related that they had heard the command but simply could not be bothered to obey. Therefore, in these two instances our conclusions as to the duration of anaesthesia are erroneous by one or two minutes to the disadvantage of the agent. Incidentally, it is worth noting that this occurred with a different subject in each instance. One further point requires emphasis: for the sake of uniformity of the experiment we used a standard concentration, namely 2.5 per cent. This is markedly more dilute than the recommended 10 per cent for buthalitone and 5 or 10 per cent for hexobarbitone; it is much more concentrated than the recommended 1 per cent for Compound 25398. This difference in concentration may well influence smoothness and duration of anaesthesia.
From the results previously discussed it becomes at once obvious that six of the drugs tested can be separated into two groups. One group consists of thiopentone and thiamylal, and the other of hexobarbitone, buthalitone, methitural and Dolitrone.
Thiopentone and thiamylal.
In double the sleep dose, which is markedly in excess of clinical doses used for induction of anaesthesia alone, these two agents are far from ultrashort acting. Both produce a transitory hypotension and diminution of minute volume which seem to return to more acceptable levels more promptly with thiopentone than with thiamylal. On the other hand, postinduction apnoea was, on the average, shorter with thiamylal than with thiopentone and the occurrence of apnoea itself was less consistent with thiamylal. Both agents were characterized by prolonged postoperative drowsiness, lack of co-ordination, diplopia and hangover. Maintenance of anaesthesia with both of these agents was invariably quite smooth.
The very frequent occurrence of double apnoea with thiopentone is of interest. It probably represents a redistribution of the drug following the primary impact of injection. Hexobarbitone, buthalitone, methitural and Dolitrone. In double the sleep dose, these four agents may truly be described as ultrashort acting with very much prompter awakening than after the first group and a conspicuous absence of the postanaesthetic phenomena observed after the administration of thiopentone and thiamylal. Average apnoea was by far the shortest after methitural, was longest after buthalitone (20 seconds), and intermediate after hexobarbitone. Against these undoubted advantages, it should be noted that entirely smooth anaesthesia was the exception rather than the rule, with spontaneous movements, Downloaded from https://academic.oup.com/bja/article-abstract/29/5/194/345433 by guest on 10 March 2018 cough and hiccough being the most prominent complications. Few of these complications were of sufficient intensity, however, to disturb markedly the progress of the anaesthesia. Our use of buthalitone 5 and 10 per cent (in clinical practice) would tend to confirm the frequent presence of undesirable muscular activity even in that concentration. This has, on occasion, been rather disturbing to the surgeon, although it was never severe enough to interfere with the procedure at hand. The relatively frequent occurrence of these phenomena with methitural under clinical conditions has also been described (Boone et al., 1956; O'Herlihy et al., 1956) . Of the four agents under consideration, hexobarbitone produced the relatively greatest cardiovascular and respiratory changes and must therefore be considered the least suitable agent in this group.
Compound 25398.
Compound 25398 was definitely an unsatisfactory drug when used as a 2.5 per cent solution. Smooth maintenance was entirely impossible in all instances, coughing, cord spasm and muscle twitching being the outstanding phenomena. Because of this marked interference with respiration, cyanosis was common and this may well be reflected in the prolonged wakening time. It is surprising, therefore, that no unpleasant postanaesthetic sequelae were noted. This agent also showed two instances of delayed apnoea, several minutes after the completion of the injection. The average apnoea time was by far the longest of all agents tested.
In a small clinical series, using a 1 per cent solution, anaesthesia was usually smooth and the agent compared very favourably in this respect with the other intravenous agents under discussion. However, even with a single sleep dose, apnoea is very much more prolonged than with other drugs, lasting about one minute after the administration of 150 to 200 mg of the compound. The smooth awakening and the absence of hangover which were noted in the experimental work have been confirmed in clinical practice.
CONCLUSIONS
Thiopentone and thiamylal have been found to be thoroughly predictable agents. They show, however, a marked prolonged effect in the relatively large doses used.
Hexobarbitone, buthalitone, methitural and Dolitrone are all markedly shorter acting, even in large doses, but it would appear that for the shorter duration one must pay the price of less smooth and more uneven anaesthesia, a price which we see no justification in exacting under normal operating room conditions. Because of its more detrimental effects, especially on respiration, hexobarbitone cannot be recommended. Dolitrone, despite its satisfactory performance in this study, must be excluded because of its unpredictability and tendency to cause phlebitis on which we have elaborated elsewhere (Wyant et al., 1956 ). Buthalitone and methitural seem to have a place mainly in outpatient practice where, for the sake of quick awakening and absence of disorientation postoperatively, it may be advisable to accept the handicap of spontaneous movements, hiccoughs, etc. For induction of longer anaesthesia, where duration of the induction agent is usually of secondary importance, we should hesitate to recommend an agent which so frequently gives minor trouble.
Compound 25398 must never be administered in a 2.5 per cent solution. The drug gives fairly smooth and short-lasting anaesthesia when administered in the 1 per cent solution and awakening is relatively prompt and free from side effects, even after repeated injections. The agent has the disadvantage of prolonged apnoea in whatever concentration it is used. Compound 25398 seems to be worthy of further study.
SUMMARY
Seven intravenous anaesthetic agents have been compared in five subjects under controlled conditions, each subject receiving double the sleep dose of each agent at weekly intervals.
The total dose required as well as cardiovascular and respiratory responses have been evaluated.
It is concluded that, in the relatively large doses used, thiopentone and thiamylal are not ultrashort acting agents. They have almost identical properties, as has also been reported by others (Tovell et al., 1955) . Of the true short acting agents, methitural and buthalitone show the great-cst promise, although they frequently do not give entirely smooth anaesthesia. The implications of this are discussed.
Compound 25398 is not to be administered in concentrations greater than 1 per cent. Its greatest disadvantage seems to lie in unduly long postinduction apnoea.
